Boston Scientific to Purchase Lumenis for $1 Billion

Boston Scientific has announced that it has agreed to acquire Lumenis, a developer of energy-based medical technology, for $1.07 billion.

The deal will earn Boston Scientific the acquired company’s laser systems, fibers and accessories designed for use in urology and otolaryngology procedures, including its MOSES laser technology, which has shown viability in managing kidney stones.

The acquisition of Lumenis, which is based in Yokneam, Israel, is anticipated to finalize in the second half of the year.